头针配合药物治疗脑卒中后抑郁疗效观察

Observations on the Efficacy of Scalp Acupuncture plus Medication for Post-stroke Depression

目的观察头针配合药物治疗脑卒中后抑郁的临床疗效。方法将60例脑卒中后抑郁患者随机分为治疗组、对照组和联合组,每组20例。治疗组采用头针治疗,对照组采用药物治疗,联合组采用头针配合药物治疗。比较3组患者治疗前后汉密尔顿抑郁量表(HAMD)24项、神经功能缺损评分量表(NISSH-)、日常生活能力的评定(ADL)中Bar-thel指数(简称BI)评分。结果治疗组愈显率为60.0%,对照组为60.0%,联合组为85.0%,联合组愈显率优于治疗组和对照组(均P<0.05)。3组患者治疗后各量表评分与同组治疗前比较,差异均具有统计学意义(P<0.01,P<0.05)。联合组治疗后HAMD评分与治疗组和对照组比较,差异均具有统计学意义(P<0.05)。结论头针配合药物是一种治疗脑卒中后抑郁的有效方法。

Objective To investigate the clinical efficacy of scalp acupuncture plus medication for post-stroke depression. Methods Sixty patients with post-stroke depression were randomly allocated to treatment, control and combination groups, 20 cases each. The treatment group received scalp acupuncture, the control group, medication and the combination group, scalp acupuncture plus medication. The Hamilton Depression Scale （HAMD） -24 item scores, the National Institute of Health Stroke Scale （NIHSS） scores, and the Barthel Index （BI） scores for assessing the activities of daily living （ADL） were compared between the three groups before and after treatment. Results The cure and marked efficacy rate was 60% in the treatment group, 60% in the control group and 85.0% in the combination group. It was significantly higher in the combination group than in the treatment group and in the control group （both P〈0.05）. There were statistically significant pre-/post-treatment differences in all the scale scores in the three groups （P〈0.01,P〈0.05）. There was a statistically significant post-treatment difference in HAMD score between the combination group and the treatment group or the control groups （P〈0.05）. Conclusion Scalp acupuncture plus medication is an effective way to treat post-stroke depression.